Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism.

Talebizadeh et al. (2008) asked if frozen blood cells could give autism clues. They grew lymphoblastoid cell lines from people with autism and matched controls.

The team scanned 470 microRNAs to see which ones were switched up or down. This was a small, first-step study to test the idea, not to make a final test.

Nine microRNAs showed different levels in the autism group. The authors say this proves the cells are worth studying further.

No numbers on age, sample size, or effect size are given. The paper simply says the approach is feasible and deserves more work.

Heald et al. (2020) extends this hunt for blood clues. They moved from cells to toddler blood and found a 34-metabolite panel that spots autism risk with 91 % specificity.

Ritz et al. (2020) also extends the idea backward in time. They found metabolic footprints in mothers’ pregnancy serum that may flag future autism.

Zhu et al. (2022) keeps the omics theme but looks at gut poop, not blood. They link low vitamin and amino-acid pathways to symptom severity.

McLennan et al. (2008) is methodologically similar: both 2008 papers test low-stress sampling. D shows cheek swabs can find genetic micro-deletions in adults with ID, while Zohreh shows stored cells can host microRNA screens for autism.

You do not need a spinal tap or fresh blood to hunt molecular flags. If a simple cell line or cheek swab can yield stable RNA or DNA, families may accept future biomarker studies more easily. Watch this space: newer work already swapped cells for toddler blood and mom serum, moving closer to a real-world screener.